Group items tagged

Vitamin D and intervention trials in prostate cancer: from theory to therapy. Schwartz GG. Ann Epidemiol. 2009 Feb;19(2):96-102. Epub 2008 Jul 10. PMID: 18619854 doi:10.1016/j.annepidem.2008.03.007 This suggests that whereas vitamin D (e.g., cholecalciferol) might prevent prostate cancer, existing prostate tumors likely would require treatment with 1,25(OH)(2)D and/or its analogs. The major obstacle to the use of 1,25(OH)(2)D in patients therapeutically is the risk of hypercalcemia. Several maneuvers to reduce this risk, including pulse dosing and the use of less calcemic 1,25(OH)(2)D analogs, have been explored in Phase I-III clinical trials. Once merely a promise, vitamin D-based therapies for prostate cancer may soon be medical practice.

Below is a list of publications covering the research being done by UW and other institutions on artemisinin and cancer. The list is organized into two categories: publications related to the effects of artemisinin and its analogs on cancer and artemisinin pharmacology and pharmacokinetics. You may find them useful when consulting with your personal physician. We have also compiled a comprehensive list of artemisinin-related articles (more than 350 publications) that you may also find useful.